Sanofi-Aventis Czech Republic made a net profit of CZK 1.19 mil in 2014, down 98.2% when compared to the previous year. Historically, company's net profit reached an all time high of CZK 73.4 mil in 2005 and an all time low of CZK 1.19 mil in 2014.
This implies return on equity of 0.186% and return on invested capital of 0.083% in 2014. That is compared to 8.10% and 2.48% average seen in the last five years.
Since 2009, net profit of the firm increased by -98.1% or -54.9% a year on average.
As far as Sanofi-Aventis Czech Republic's peers are concerned, Roche Czech Republic generated ROE of 8.00% and ROCE of 5.39% in 2014, Bayer Czech Republic's profitability reached 40.5% and 28.9%, respectively. Amgen Czech Republic operated with 21.7% and 45.1% returns in 2014..